Distinct Cellular Mechanisms of Cholinergic and Beta-adrenergic Sweat Secretion
Overview
Affiliations
The cholinergic and beta-adrenergic sweat secretions from human sweat glands differ with respect to secretory rates and their susceptibility to cystic fibrosis (CF). Using the cultured beta-adrenergic-sensitive sweat secretory cell, we sought to determine the intracellular electrophysiological mechanisms underlying these functional differences. We found that the cholinergic agonist methacholine (10(-6) M) induced a Ca(2+)-dependent biphasic membrane potential (Vm) response: an initial hyperpolarization and a secondary depolarization. The initial hyperpolarization was independent of bath Cl- and dependent on transmembrane K+ gradient. However, the secondary depolarization of Vm was dependent on bath Cl-. In contrast, the beta-adrenergic agonist isoproterenol (10(-5) M) induced a monophasic depolarization of Vm. This depolarization was 1) dependent on bath Cl-, 2) independent of K+ conductance (GK) blocker Ba2+ (5mM), 3) unaffected by the methacholine-induced secondary depolarization of Vm, and 4) absent in cells derived from CF subjects. These results indicated that the cholinergic agonist-induced secretion mainly involves the activation of Ca(2+)-dependent GK and Cl- conductance (GCl), whereas the beta-adrenergic secretion seems to mainly depend on the activation of cystic fibrosis transmembrane conductance regulator-GCl.
Variation in CFTR-dependent 'β-sweating' among healthy adults.
DeRose L, Kim J, Farahmand M, Shinbashi M, Joo N, Wine J PLoS One. 2022; 17(3):e0265432.
PMID: 35312728 PMC: 8936459. DOI: 10.1371/journal.pone.0265432.
Zhang L, Zhang X, Du L, Zhang C, Li H Exp Anim. 2020; 70(2):218-224.
PMID: 33298631 PMC: 8150243. DOI: 10.1538/expanim.20-0144.
Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults.
Kim J, Farahmand M, Dunn C, Milla C, Horii R, Thomas E Sci Rep. 2018; 8(1):16233.
PMID: 30389955 PMC: 6214959. DOI: 10.1038/s41598-018-34308-8.
Pondugula S, Kampalli S, Wu T, De Lisle R, Raveendran N, Harbidge D BMC Physiol. 2013; 13:6.
PMID: 23537040 PMC: 3622586. DOI: 10.1186/1472-6793-13-6.
Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms.
Lisa S, Domingo B, Martinez J, Gilch S, Llopis J, Schatzl H J Biol Chem. 2012; 287(44):36693-701.
PMID: 22955286 PMC: 3481273. DOI: 10.1074/jbc.M112.398776.